Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer

Annals of Oncology

Volumn 11, Issue 7, 2000, Pages 815-819

  Hatanaka, H ^a   Abe, Y ^b   Kamiya, T ^a   Morino, F ^a   Nagata, J ^a   Tokunaga, T ^a   Oshika, Y ^a   Suemizu, H ^c   Kijima, H ^a   Tsuchida, T ^a   Yamazaki, H ^a   Inoue, H ^a   Nakamura, M ^a   Ueyama, Y ^a,c  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kanagawa National Hospital   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

IL 10 receptor mRNA; Interleukin (IL) 10 mRNA; Non small cell lung cancer (NSCLC); Prognosis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MESSENGER RNA;

ADENOSQUAMOUS CARCINOMA; ARTICLE; ENZYME IMMUNOASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033811639     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008375208574     Document Type: Article

References (23)

1. Tumour immunogenicity: How far can it be pushed?
2. Local expression of antiinflammatory cytokines in cancer
3. Tumour-induced regulation of suppressor macrophage nitric oxide and TNF-Aalpha production. Role of tumor-derived IL-10, TGF-beta and prostaglandin E2
4. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
5. Autocrine production of interleukin-8 decreases lung cancer proliferation and augments lymphocyte-tumour adhesion
6. On the relative roles of interleukin-2 and interleukin-10 in the generation of lymphokine-activated killer cell activity
7. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma
8. IL-10 acts on the antigen-presenting cell to inhibit cytokine production Thl cells
9. Inhibition of Lagerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance
10. Interleukin-10 and cancer
11. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells
12. Human non-small-cell lung cancer cells express a type 2 cytokine pattern
13. Comparative analysis of interleukin 15 and interleukin 2 for induction of killer activity and of type 2 cytokine production by mononuclear cells from lung cancer patients
14. The Japanese Lung Cancer Society. General Rule for Clinical and Pathological Record of Lung Cancer
15. Expression of the multidrug resistance gene (MDR1) in non-small-cell lung cancer
16. Multidrug resistance gene (MDR1) expression in human tumor xenografts
17. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms
18. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
19. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
20. Non-small-cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production
21. Quantitative analysis of Th1, Th2 and TGF-b1 cytokine expression in tumor, TIL and PBL of non-small-cell lung cancer patients
22. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer
23. Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle